On April 13, 2016, Anhui Yinfeng Pharmaceutical Co., Ltd. was officially listed on the National Equities Exchange and Quotations System for Small and Medium-sized Enterprises, stock abbreviation: Yinfeng shares, and stock code: 836181.

In July 2014, in order to regulate corporate governance and enter the capital market, the company hired three intermediary agencies, namely Shenwan Hongyuan Securities, Lixin Certified Public Accountants, and Beijing Jinlue Law Firm, to conduct preliminary due diligence, and subsequently signed the company’s shareholding reform and national small and medium-sized enterprises with three intermediary agencies Related agreements for the listing of the share transfer system. With the help of Taihe County Government, Development Zone Management Committee, Taihe County Economic and Information Commission and other government departments, Yinfeng Pharmaceutical completed issues such as corporate financial regulations and corporate asset ownership before the company’s shareholding system reform, and submitted application materials for the company’s listing Buy more time.

The application materials for the listing of Yinfeng shares were officially accepted by the company on November 16, 2015, and the letter of approval from the company on February 4, 2016 was obtained on February 4, 2016, and it was officially listed on the National SME Share Transfer System on April 13, 2016 .

Yinfeng's completion of the NEEQ listing is only the first step. As an unlisted public company, standardized corporate governance and information disclosure are responsible to all investors. In the future, Yinfeng shares will assume more social responsibilities, and our goal is to become a respected public company.